Preliminary survival analysis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Lymph Nodes Cells, Cultured Bile Ducts, Intrahepatic

Organisms3

Strongylida Mice, Inbred C57BL Mice, Knockout

Diseases60

Breast Neoplasms Neoplasm Recurrence, Local Lung Neoplasms Disease Progression Lymphatic Metastasis Adenocarcinoma Recurrence Liver Neoplasms Brain Neoplasms Carcinoma, Squamous Cell Carcinoma Prosthesis Failure Colorectal Neoplasms Neoplasm Metastasis Neoplasms Stomach Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Carcinoma, Non-Small-Cell Lung Carcinoma, Hepatocellular Glioblastoma Kidney Failure, Chronic Melanoma Postoperative Complications Esophageal Neoplasms Pancreatic Neoplasms Prostatic Neoplasms Bone Neoplasms Rectal Neoplasms Skin Neoplasms Kidney Neoplasms Cholangiocarcinoma Glioma Nasopharyngeal Neoplasms Head and Neck Neoplasms Carcinoma, Renal Cell Bile Duct Neoplasms Astrocytoma Osteosarcoma Inhalant Abuse Sarcoma HIV Infections Colonic Neoplasms Chronic Disease Urinary Bladder Neoplasms Multiple Myeloma Carcinoma, Ductal, Breast Endometrial Neoplasms Disease Models, Animal Mouth Neoplasms Genetic Predisposition to Disease Heart Failure Lymphoma, Large B-Cell, Diffuse Carcinoma, Transitional Cell Lymphoma, Non-Hodgkin Stroke Oligodendroglioma Tongue Neoplasms Acute Disease Acquired Immunodeficiency Syndrome

Chemicals and Drugs24

Tumor Markers, Biological Antineoplastic Agents Ki-67 Antigen Cisplatin Cyclophosphamide Fluorouracil Receptor, erbB-2 Neoplasm Proteins Doxorubicin Tumor Suppressor Protein p53 Receptors, Estrogen Biological Markers RNA, Messenger Antibodies, Monoclonal Receptors, Progesterone Prednisone Vincristine Proto-Oncogene Proteins Immunosuppressive Agents Tumor Suppressor Proteins Antineoplastic Agents, Hormonal Survival of Motor Neuron 1 Protein Receptor, Epidermal Growth Factor DNA, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment108

Survival Analysis Survival Rate Kaplan-Meier Estimate Prognosis Disease-Free Survival Proportional Hazards Models Treatment Outcome Retrospective Studies Follow-Up Studies Neoplasm Staging Multivariate Analysis Risk Factors Cohort Studies Prospective Studies Immunohistochemistry Predictive Value of Tests Crystallization Combined Modality Therapy Registries Life Tables Antineoplastic Combined Chemotherapy Protocols Risk Assessment Incidence Tissue Array Analysis Chemotherapy, Adjuvant Prosthesis Failure Regression Analysis Neoplasm Grading Reoperation Longitudinal Studies Analysis of Variance Models, Statistical Chi-Square Distribution Cause of Death Probability Severity of Illness Index SEER Program Biostatistics Gene Expression Profiling Radiotherapy, Adjuvant Crystallography, X-Ray Risk Reproducibility of Results Actuarial Analysis Mortality X-Ray Diffraction Drug Administration Schedule Kidney Transplantation Pilot Projects Neoadjuvant Therapy Statistics, Nonparametric Immunoenzyme Techniques Data Interpretation, Statistical Treatment Failure Hip Prosthesis Cementation Reverse Transcriptase Polymerase Chain Reaction Case-Control Studies Sensitivity and Specificity Logistic Models Prosthesis Design Remission Induction ROC Curve Tumor Burden Oligonucleotide Array Sequence Analysis Renal Dialysis Liver Transplantation Transplantation, Homologous Clinical Trials as Topic Breeding Randomized Controlled Trials as Topic Patient Selection Life Expectancy Models, Biological Drug Therapy, Combination Blotting, Western Confidence Intervals Mitotic Index Epidemiologic Methods Chemoradiotherapy Hepatectomy Palliative Care Polymerase Chain Reaction Chemoembolization, Therapeutic Questionnaires Odds Ratio Lymph Node Excision Knee Prosthesis Arthroplasty, Replacement, Hip Statistical Distributions Linear Models Multicenter Studies as Topic Double-Blind Method Cluster Analysis Heart Transplantation Endpoint Determination Disease Models, Animal Gastrectomy Prevalence Radiotherapy Magnetic Resonance Imaging Esophagectomy Tomography, X-Ray Computed CD4 Lymphocyte Count Joint Prosthesis Feasibility Studies Cystectomy Biometry

Psychiatry and Psychology3

Cannibalism Inhalant Abuse Smoking

Phenomena and Processes32

Cell Survival Time Factors Graft Survival Crystallization Gene Expression Regulation, Neoplastic Apoptosis Chi-Square Distribution Probability Longevity Risk Mutation Signal Transduction X-Ray Diffraction Cell Proliferation Sensitivity and Specificity Genotype Graft Rejection Pregnancy Breeding Algorithms Dose-Response Relationship, Drug Odds Ratio Gene Expression Phenotype Statistical Distributions Polymorphism, Single Nucleotide Vascular Patency Up-Regulation Genetic Predisposition to Disease Drug Resistance, Neoplasm CD4 Lymphocyte Count Cell Division

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena5

Survival Age Distribution Quality of Life Socioeconomic Factors Sex Distribution

Humanities1

Quality of Life

Information Science14

Survival Rate Registries Life Tables Incidence Cause of Death SEER Program Mortality Data Interpretation, Statistical Databases, Factual Algorithms Life Expectancy Questionnaires Molecular Sequence Data Prevalence

Named Groups4

Infant, Newborn Patient Dropouts Survivors European Continental Ancestry Group

Health Care64

Survival Analysis Survival Rate Kaplan-Meier Estimate Disease-Free Survival Proportional Hazards Models Treatment Outcome Retrospective Studies Follow-Up Studies Multivariate Analysis Risk Factors Cohort Studies Prospective Studies Predictive Value of Tests Age Factors Registries Life Tables Risk Assessment Incidence Regression Analysis Longitudinal Studies Analysis of Variance Sex Factors Models, Statistical Chi-Square Distribution Cause of Death Probability Severity of Illness Index SEER Program Age of Onset Risk Reproducibility of Results Actuarial Analysis Mortality Pilot Projects Comorbidity Statistics, Nonparametric Data Interpretation, Statistical Treatment Failure Case-Control Studies Sensitivity and Specificity Logistic Models ROC Curve Clinical Trials as Topic Randomized Controlled Trials as Topic Patient Selection Life Expectancy Confidence Intervals Epidemiologic Methods Bias (Epidemiology)Palliative Care Age Distribution Questionnaires Odds Ratio Statistical Distributions Outcome Assessment (Health Care)Linear Models Multicenter Studies as Topic Double-Blind Method Cluster Analysis Prevalence Socioeconomic Factors Feasibility Studies Biometry Sex Distribution

Geographicals14

United States France Europe Macau Spain Italy China Japan Sweden Denmark Iran Taiwan Australia Netherlands

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Analysis Survival Rate Cell Survival Kaplan-Meier Estimate Prognosis Disease-Free Survival Proportional Hazards Models Treatment Outcome Retrospective Studies Survival Time Factors Follow-Up Studies Neoplasm Staging Graft Survival Multivariate Analysis Risk Factors Cohort Studies Tumor Markers, Biological Prospective Studies Immunohistochemistry Breast Neoplasms Predictive Value of Tests Crystallization Age Factors Neoplasm Recurrence, Local Combined Modality Therapy Lung Neoplasms Disease Progression Registries Life Tables Lymphatic Metastasis Adenocarcinoma Antineoplastic Combined Chemotherapy Protocols Recurrence Risk Assessment Incidence Liver Neoplasms Brain Neoplasms Tissue Array Analysis Carcinoma, Squamous Cell Chemotherapy, Adjuvant Carcinoma Prosthesis Failure Colorectal Neoplasms Regression Analysis Neoplasm Metastasis Neoplasm Grading Gene Expression Regulation, Neoplastic Antineoplastic Agents Apoptosis Reoperation United States Longitudinal Studies Neoplasms Stomach Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Analysis of Variance Sex Factors Models, Statistical Carcinoma, Non-Small-Cell Lung Cell Line, Tumor Chi-Square Distribution Cause of Death Probability Longevity Carcinoma, Hepatocellular Severity of Illness Index SEER Program Biostatistics Glioblastoma Gene Expression Profiling Ki-67 Antigen Radiotherapy, Adjuvant Crystallography, X-Ray Kidney Failure, Chronic Age of Onset Risk Reproducibility of Results Melanoma Postoperative Complications Mutation Signal Transduction Actuarial Analysis Esophageal Neoplasms Mortality Cannibalism X-Ray Diffraction Cisplatin Cell Proliferation Drug Administration Schedule Pancreatic Neoplasms Infant, Newborn Kidney Transplantation Pilot Projects Cyclophosphamide Fluorouracil Comorbidity Neoadjuvant Therapy Statistics, Nonparametric

No FAQ available that match "preliminary survival analysis"